Barrington, Illinois Clinical Trials

A listing of Barrington, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

migraine in children
ly573144
lasmiditan
acute treatment
Alexian Brothers Medical Center
 (7.2 away) Contact site
  • 139 views
  • 26 Sep, 2021
  • +243 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

hormonal contraception
atopy
eczema
topical agents
lebrikizumab
Arlington Dermatology
 (9.0 away) Contact site
  • 154 views
  • 27 Sep, 2021
  • +357 other locations
NICU2HOME+: Supporting Illinois Families

The purpose of this project is to provide a stepwise, methodical approach to developing and testing the ability of NICU2HOME+ to support diverse Illinois families of premature infants during and after their NICU stays in an effort to address health equity, improve parenting, and reduce costs. There are 3 objectives …

prematurity
Centra Dupage Hospital
 (7.1 away) Contact site
  • 0 views
  • 09 Jul, 2021
  • +2 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

headache
ly573144
preventive medication
lasmiditan
Alexian Brothers Medical Center
 (7.2 away) Contact site
  • 130 views
  • 27 Sep, 2021
  • +243 other locations
A Study of Baricitinib in Participants With Rheumatoid Arthritis

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).

DMARD
body mass index
tumor necrosis factor alpha
tumor necrosis factor
tumour necrosis
Greater Chicago Specialty Physicians, LLC
 (7.1 away) Contact site
  • 301 views
  • 26 Sep, 2021
  • +171 other locations
A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC MK-7339-008/KEYLYNK-008)

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatment of squamous NSCLC. The study's 2 primary hypotheses are: Pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance olaparib placebo with respect to progression-free survival (PFS) per RECIST 1.1 by …

Oncology of Northshore ( Site 0036)
 (8.6 away) Contact site
  • 119 views
  • 26 Sep, 2021
  • +202 other locations
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

The purpose of this research study is to evaluate whether using the the IMPELLA CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.

Advocate Edward Hospital
 (8.9 away) Contact site
  • 14 views
  • 30 Jul, 2021
  • +53 other locations
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

A clinical study to evaluate the long-term safety and tolerability of an investigational drug in people with schizophrenia. This study is accepting male and female participants between 18 years old -65 years old who have been diagnosed with schizophrenia. This study will be conducted in approximately 50 study centers worldwide. …

scid
antipsychotics
quetiapine
Alexian Brothers Center for Psychiatric Research
 (7.2 away) Contact site
  • 100 views
  • 19 Aug, 2021
  • +45 other locations
Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The purpose of this study is to evaluate the efficacy and safety of MK-8189 at a range of doses (8 mg, 16 mg, and 24 mg once daily) in adult participants who have an acute episode of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) …

risperidone
Alexian Center for Psychiatric Research ( Site 1000)
 (7.2 away) Contact site
  • 0 views
  • 26 Sep, 2021
  • +65 other locations
A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

This is a global, randomized, controlled, open-label Phase 3 study designed to assess the long-term efficacy and safety of UGN-102 (mitomycin) for intravesical solution with or without () transurethral resection of bladder tumors (TURBT) versus TURBT alone for the treatment of patients with low grade intermediate risk non-muscle-invasive bladder cancer …

transurethral resection
transurethral resection of bladder tumor
anesthesia
neutrophil count
EGFR
Comprehensive Urologic Care
 (3.8 away) Contact site
  • 0 views
  • 09 Jul, 2021
  • +124 other locations